


Methods of Cancer. Diagnosis, Therapy, and Prognosis, Vol. 8: Brain Cancer
Hayat, M.
ISBN-13: 9789048186648
SPRINGER
Octubre / 2010
1ª Edición
Inglés
Tapa dura
395 pags
1600 gr
20 x 27 x 3 cm
Recíbelo en un plazo De 2 a 3 semanas
This eighth volume in the series Methods of Cancer Diagnosis, Therapy, and Prognosis discusses in detail the classification of the CNS tumors as well as brain tumor imaging. Scientists and Clinicians have contributed state of the art chapters on their respective areas of expertise, providing the reader a whole field view of the CNS tumors and brain tumor imaging in Europe. This fully illustrated volume: Explains the genetics of malignant brain tumors and gene amplification using quantitative-PCR; Presents a large number of standard and new imaging modalities, including magnetic resonance imaging, functional magnetic resonance imaging, diffusion tensor imaging, amide proton transfer imaging, positron emission tomography, single photon emission computed tomography, magnetic resonance single voxel spectroscopy and intraoperative ultrasound imaging, for staging and diagnosing various primary and secondary brain cancers; Explains the usefulness of imaging methods for planning and monitoring (assessment) therapy for cancers; Discusses diagnosis and treatment of primary CNS lymphomas, CNS atypical teratoid/rhabdoid and CNS Rosai-Dorfman disease; Includes the subject of translational medicine. Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Content Level » Professional/practitioner
Keywords » Cancer Methods
Related subjects » Cancer Research - Medicine - Oncology & Hematology - Radiology
Table of contents
1. The World Health Organization Classification of the Central Nervous System
Tumors: an Update Using Imaging; Shiori Amemiya Introduction Astrocytic Tumors
Pilomyxoid astrocytoma Neuronal and Mixed Neuronal-Glial Tumors Papillary Glioneuronal
Tumor Extraventricular Neurocytoma Rosette-Forming Glioneuronal Tumor of the
Fourth Ventricle Other Neuroepithelial Tumors Angiocentric Glioma Tumors of
the Pineal Region Papillary Tumor of the Pineal Region Embryonal Tumors Medulloblastoma
with Extensive Nodularity Anaplastic Medulloblastoma References 2. Brain Tumor
Imaging: European Association of Nuclear Medicine Procedure Guidelines; Thierry
Vander Borght, Susanne Asenbaum, Peter Bartenstein, Christer Halldin, Ozlem
Kapucu, Koen Van Laere, Andrea Varrone, and Klaus Tatsch Introduction Background
Information and Definitions Common Indications Indications Detection of Viable
Tumor Tissue Tumor Delineation Selecting the Best Biopsy Site Noninvasive Tumor
Grading Therapy Planning Tumor Response Contraindications (relative) Procedure
Patient Preparation Prearrival Preinjection Information Pertinent to Performance
of the Procedure Precautions and Conscious Sedation Radiopharmaceutical Radiopharmaceutical
Recommended Dosage Radiation Dosimetry Radiation Dosimetry of Brain Transmission
Scans Data Acquisition Time Delay from Injection to Beginning of Data Acquisition
Set-up for Data Acquisition Image Processing PET Reconstruction SPECT Reconstruction
Reformatting of PET and SPECT Images Comparative Evaluation Interpretation Criteria
Visual Interpretation Quantification Reporting General Body of the Report Interpretation
and Conclusion Issues Requiring Further Clarification References 3. Assessment
of Heterogeneity in Malignant Brain Tumors; Timothy E. Van Meter, Gary Tye,
Catherine Dumur, and William C. Broaddus Introduction The problem of Heterogeneity
and Its Clinical Significance Previous Studies Assessing Molecular Heterogeneity
of Tumors Use of Stereotactic Neuroimaging Systems for Tumor Sampling Methodology
Description of Method MRI-Guided Stereotactic Biopsy Integrated Histopathological
Scoring Use of Genomics Technologies for Regional Molecular Profiling Results
Histopathological Considerations Assessing Quality of Biopsy Extracts Genomic
Assessment of Regional Tumor Phenotype Validation Studies Discussion Utility
of Stereotactic Biopsy for Tumor Characterization Future Technical Applications
Clinical Impact of Improved Tumor Characterization References 4. Diagnosing
and Grading of Brain Tumors: Immunohistochemistry; Hidehiro Takei and Suzanne
Z. Powell Introduction Immunohistochemical Markers for Diagnosis and Differential
Diagnosis of Brain Tumors Immunohistochemical Markers Routinely Used In Diagnostic
Neuro-Oncology Practice New Immunohistochemical Markers Applicable to Brain
Tumor Diagnosis Useful Immunohistochemical Markers for Differential Diagnosis
of Brain Tumors Immunohistochemistry as a Useful Adjunct in Grading of Brain
Tumors: Ki-67 and Phospho-Histon H3 Immunohistochemical and Analytical Methods
References 5. Malignant Brain Tumors: Roles of Aquaporins; Jerome Badaut and
Jean-Francois Brunet Introduction Aquaporin Expression in Normal Brain and its
Function Aquaporin Distribution and its Potential Role Aquaporin Astrocyte Endfeet
Marker in Brain Water Homeostasis Involvement of Aquaporin 9 Expression in Brain
Energy Metabolism Aquaporin Distribution in Tumors: Role in Prognosis and Treatment
Aquaporin in tumors: Water Homeostasis or Cell Migration? Aquaporin 4 in Tumors:
Biomarker for Tumor Classification AQP9 in Brain Tumors: New Findings References
6. Brain Metastases: Gene Amplification Using Quantitative Real-time Polymerase
Chain Reaction Analysis; Carmen Franco-Hernandez, Miguel Torres-Martin, Victor
Martinez-Glez, Carolina Pena-Granero, Javier S. Castresana, Cacilda Casartelli
and Juan A. Rey Introduction Objectives Equipment and Procedure DNA Extraction
Quantitative-PCR: Amplification Status Procedure Results Further Considerations
References 7. Cyclic Amp Phosphodiesterase-4 in Brain Tumor Biology: Immunochemical
Analysis; B. Mark Woerner and Joshua B. Rubin Introduction Materials and Methods
Western Blotting Materials Methods Immunohistochemistry Materials Methods Immunocytochemistry
Materials Methods Results and Discussion References 8. Radiosurgical Treatment
of Progressive Malignant Brain Tumors; Cole A. Giller Introduction Methodology
of Treatment Philosophy Methodology of Indications Methodology of Choice of
Fractionation Schedule Methodology of Dosimetry Construction of Hypofractionated
Plans Case Example Cohort Study References 9. Anti-Vascular Therapy for Brain
Tumors; Florence M. Hofman and Thomas C. Chen Introduction Specific Drug Targets
Angiogenic Growth Factors Growth Factor Receptor Inhibitors Endothelial Cell
Adhesion and Migration Bone Marrow-derived Endothelial Progenitor Cells Conclusion
References 10. Glial Brain Tumors: Antiangiogenic Therapy; William PJ Leenders
and Pieter Wesseling Clinical Features of Glioma Histopathology and Genetics
of Gliomas Current Treatment Modalities Antiangiogenesis as Antitumor Therapy
Vascular Endothelial Growth Factor-A and Angiogenesis Preclinical Antiangiogenesis
Therapy for Diagnosis Blood Vessel Normalization Clinical Experience with Antiangiogenesis
Therapy Future Perspectives References 11. Brain Tumors: Amide Proton Transfer
Imaging; Jinyuan Zhou and Jaishri O. Blakeley Introduction Chemical Exchange-Dependant
Saturation Transfer Imaging: Principles and Applications Magnetization Transfer
Contrast, Chemical Exchange-Dependant Saturation Transfer and Amide Proton Transfer
Amide Proton Transfer Imaging of Experimental Brain Tumor Models Amide Proton
Transfer Imaging of Human Brain Tumors References 12. Diffusion Tensor Imaging
in Rat Models of Invasive Brain Tumors; Sungheon Kim, Steve Pickup, and Harish
Poptani Introduction Imaging Tissue Microstructure Diffusion Tensor Diffusion
Tensor Metrics Data Acquisition methods Rat Brain Tumor Models 9L Gliosarcoma
C6 Glioma F98 Glioma Mayo 22 Hunman Brain Tumor Xenograft Future Considerations
Tractography Tumor Cell Density and Diffusion Anisotropy References 13. Brain
Tumors: Diffusion Imaging and Diffusion Tensor Imaging; Pia C. Sundgren, Yue
Cao, and Thomas L. Chenevert Introduction Imaging Techniques Diffusion Weighted
Imaging Diffusion Tensor Imaging Diffusion Imaging in Tissue Characterization
Diffusion Imaging in Tumor Grading Diffusion Imaging in Presurgical Planning
Diffusion Imaging in Treatment Follow-up Diffusion Imaging in Differentiation
of Recurrent Tumor From Radiation Injury and Postsurgical Injury Pitfalls Future
Applications References 14. Brain Tumors: Planning and Monitoring Therapy with
Positron Emission Tomography; D.J. Coope, K. Herholz, and P. Price Introduction
Imaging Brain Tumors with Positron Emission Tomograoghy and FDG Amino Acid PET
in Brain Tumors Positron Emission Tomography Imaging in Less Common Tumor Types
Delineation of Tumor Extent for Treatment Planning Minimizing Damage to Uninvolved
Brain Structures Monitoring Brain Tumors-When is the best time to intervene?
Selection of Treatment Modalities
Assessing Response to Treatment and Prognosis The Future of PET Imaging in Brain
Tumors References 15. Clinical Evaluation of Primary Brain Tumor: O-(2-[18F]Fluorethyl)-L-Tyrosine
Positron Emission Tomography; Matthias Weckesser and Karl-Josef Langen Introduction
Intensity and Dynamics of O-(2-[18F]Fluorethyl)-L-Tyrosine-Uptake Correlation
of O-(2-[18F]Fluorethyl)-L-Tyrosine-Uptake With Morphological Imaging Recommendations
for Image Acquisition and Interpretation Clinical Application References 16.
Combined use of [F-18]Fluorodeoxyglucose and [C-11]Methionine in 45 PET-Guided
Stereotactic Brain Biopsies; Benoit Pirotte Introduction Materials and Methods
Patient Selection Stereotactic PET Data Acquisition Analysis of Stereotactic
PET Images and Target Definition Data Analysis Results Abnormal Met and FDG
Uptakes Lesions in the Cortical Grey Matter Lesions in the Sub-cortical Grey
Matter Specific Contribution of Met-PET and FDG-PET Specificity and Sensitivity
to Detect Tumor Tissue Discussion PET for the Guidance of Stereotactic Brain
Biopsy Choice of Radiotracer Accuracy of Stereotactic PET Coregistration Comparison
Between Met and FDG References 17. Hemorrhagic Brain Neoplasm: 99MTc-Methoxyisobutyl
Isonitrile-Single Photon Emission Computed Tomography; Filippo F. Angileri,
Fabio Minutoli, Domenico La Torre and Sergio Baldari Introduction Radiopharmaceutical
and Technical Issues 99mTc-MIBI-SPECT in Brain Tumors Evaluation 99mTc-MIBI-SPECT
in Hemorrhagic Brain Neoplasm References 18. Brain Tumor Imaging Using p-[123I]IODO-L-Phenylalanine
and SPECT; Dirk Hellwig Introduction Imaging Method Preparation of 123I-IPA
Patient Preparation and Administration of 123I-IPA SPECT Acquisition Correlative
Nuclear Magnetic Resonance Imaging Coregistration of SPECT and NMR Images Qualitative
Interpretation and Quantitative Image Analysis Results of Brain Tumor Imaging
Using 123I-IPA Initial Evaluation of Suspected Brain Tumors Evaluation of Suspected
Recurrence or Progression Quantitative Criteria for the Evaluation of Brain
Lesions by IPA-SPECT Comparison of 123I-IPA and 123I-IMT Dosimetry of 123I-IPA
Discussion Potential Advancements Acknowledgement References 19. Diagnosis and
Staging of Brain Tumors: Magnetic Resonance Single Voxel Spectra; Margarida
Julia-Sape, Carles Majos and Carles Arus Introduction Single Voxel Magnetic
Resonance Spectroscopy What Does Single Voxel MRS Tell us about a Brain Tumor
Information Provided by a Single Voxel MR Spectrum Methods How to Perform a
Single Voxel Magnetic Resonance Spectroscopy Study When a Brain Tumor is Suspected
Acquisition Parameters for Single Voxel Magnetic Resonance Spectroscopy Reporting
on a Single Voxel Magnetic Resonance Spectroscopy Study Quantifying a Magnetic
Resonance Spectroscopy Study: Processing a Single Voxel Magnetic Resonance Spectrum
Quantifying an MRS Study: Ratio-Based Determinations Quantifying an MRS Study:
Classifiers and Decision-Support Systems When There is an Indication for a SV
MRS Exam Discrimination Between Tumor and Pseudotumoral Lesion Tumor Classification
Follow-up of Brain-Tumors after Treatment References 20. Parallel Magnetic Resonance
Imaging Acquisition and Reconstruction: Application to Functional and Spectroscopic
Imaging in Human Brain; Fa-Hsuan Lin and Shang-Yueh Tsai Introduction Principles
of Parallel MRI Parallel Magnetic Resonance Imaging Acquisitions Parallel Magnetic
Resonance Imaging Reconstructions Mathematical Formulation Application: Sense
Human Brain Functional Magnetic Resonance Imaging Application: Sense Proton
Spectroscopic Imaging Conclusion References 21. Intra-Axial Brain Tumors: Diagnostic
Magnetic Resonance Imaging; Elias R. Melhem and Riyadh N. Alokaili Introduction
Classification and Overview of Central Nervous System Tumors Intra-Axial Tumor
Imaging Protocol Diffusion Imaging Diffusion Tensor Imaging Perfusion Magnetic
Resonance Imaging Proton Magnetic Resonance Spectroscopy Basics of Central Nervous
System Tumor Image Interpretation General Conventional Magnetic Resonance Imaging
Appearance of Intra-axial Tumors Appearance of Specific Intra-axial Brain Tumors
on Advanced Magnetic Resonance Imaging Primary (non-lymphomatous) Neoplasms
Secondary Neoplasms (Metastases) Lymphoma Tumefactive Demyelinating Lesions
Brain Abscess Encephalitis Approach to an Unknown Intra-axial Brain Tumor Limitations
and Future Direction References 22. Brain Tumors: Apparent Diffusion Coefficient
at Magnetic Resonance Imaging; Fumiyuki Yamasaki, Kazuhiko Sugiyama and Kaoru
Kurisu Introduction Diffusion-Weighted Imaging and T2 Shine-Through Diffusion-Weighted
Images Sequences Cellularity and Apparent Diffusion Coefficient Clinical Application
of Apparent Diffusion Coefficient in Brain Tumor Grade and Apparent Diffusion
Coefficient Differentiation of Brain Tumors and Apparent Diffusion Coefficient
Astrocytomas, Oligodendrogliomas, and Ependymomas Dysembryoplastic Neuroepithelial
Tumors Medulloblastomas, Primitive Neuroectodermal Tumors, and Ependymomas Central
Neurocytomas and Subependymomas Hemanglioblastomas and Other Posterior Cranial
Fossa Tumors Glioblastomas, Metastatic Tumors, and Malignant Lymphomas Histologic
Subtyping of Meningiomas and schawannomas Pituitary and Parasellar Tumors and
Other Tumors Visualizing Tumor Infiltration Distinguishing Tumor Recurrence
from Radiation Necrosis Monitoring Treatment Effects Distinguishing Tumor Recurrences
from Resection Injury Distinguishing Brain Abscesses from Cystic or Necrotic
Malignant Tumors Limitations: Variations in Apparent Diffusion Coefficient Measurements
and Selection of Regions of Interest Future Directions References 23. Magnetic
Resonance Imaging of Brain Tumors Using Iron Oxide Nanoparticles; Matthew A.
Hunt and Edward A. Neuwelt Introduction Biologic and Molecular Characteristics
Imaging Characteristics Experimental Studies Human Imaging Intraoperative Magnetic
Resonance Imaging Future Directions References 24. Metastatic Solitary Malignant
Brain Tumor: Magnetic Resonance Imaging; Nail Bulakbasi and Murat Kocaoglu Introduction
Screening and Initial Evaluation Imaging Protocol Imaging Properties of Solitary
Brain Metastasis Differential Diagnosis of Solitary Brain Metastasis Future
Trends and Conclusion References 25. Brain Tumor Resection: Intraoperative Ultrasound
Images; Christof Renner Introduction General Principles Principles of Intraoperative
Ultrasound Examination Efficacy of Intraoperative Ultrasound References 26.
Primary Central Nervous System Lymphomas: Salvage Treatment; Michele Reni, Elena
Mazza, and Andres J. M. Ferreri Introduction Diagnostic Workup at Relapse Prognostic
Factors Methodological Issues Whole-Brain Radiotherapy Chemotherapy Single Agent
Chemotherapy Retreatment with Methotrexate Combination Chemotherapy Monoclonal
Antibodies High-Dose Chemotherapy and Autologous Stem-cell Rescue Intrathecal
Chemotherapy Conclusions References 27. Central Nervous System Atypical Teratoid/Rhabdoid
Tumors: Role of Insulin-Like Growth Factor I Receptor; Michael A. Grotzer, Tarek
Shalaby and Alexandre Arcaro Insulin-Like Growth Factor 1 Receptor Role in CNS
Atypical Teratoid/Rhabdoid Tumor Analytical Methods Immunohistochemistry Immunoprecipitation
Western Blotting Quantitative RT-PCR Cell Viability Detection of Apoptosis Evaluation
of IGF-I/-II/IGF-IR IN CNS AT/RT Down-Regulation of IGF-IR Therapeutic Significance
of IGF-IR IN CNS AT/RT References 28. Central Nervous System Rosai-Dorfman Disease;
Osama Raslan, Leena M. Ketonen, Gregory N. Fuller and Dawid Schellingerhout
Introduction, Epidemioligy and Etiology Intracranial Rosai Dorfman Disease:
Clinical and Imaging Findings and Diffrential Diagnosis Spinal Rosai Dorfman
Disease: Clinical and Imaging Findings Histopathological and Diffinate Diagnosis
Clinical Course and Treatment References
Fax91 448 21 88
DirC / Raimundo Lulio, 1, 28010 Madrid, España.
Mailpedidosweb@axon.esPrivacidadCondiciones de ventaQuiénes SomosAvisoContacto© 2021 Axón Librería S.L.
v1.47.1